Zydus Lifesciences Share Price Hits Fresh 52-Week High at Rs 1,232: Key Reasons Behind the Rally
- September 29, 2026
- Posted by: Harsh Piplani
- Category: News
Zydus Lifesciences Share Price opened the session in positive territory and moved to a fresh 52-week high, with the stock last seen at Rs 1,222.9, up 0.90% from the previous close of Rs 1,212. The session high matched the one-year peak at Rs 1,232, while the market capitalisation stood at Rs 1,19,899.96 crore. The move places Zydus Lifesciences stock news firmly in today’s stock market discussion because the price event is verified by the data, even though the supplied figures do not establish a company-specific catalyst. For readers tracking Zydus Lifesciences Share Price Today on Univest, the key point is straightforward: the stock is trading near its yearly high, and the market is pricing it close to the top of the current 52-week range.
From a news and search perspective, this is the kind of Zydus Lifesciences Share Price update that draws attention on account of the fresh 52-week high itself. Univest tracks the event alongside the day’s price move, market cap, valuation ratios and sector context so the move can be read in a structured way. The supplied data confirms the price action, but it does not assign a cause beyond the fact that the stock reached a fresh yearly high. That makes the latest Zydus Lifesciences Stock News useful for investors who want a factual share price update rather than a narrative built on assumptions.
Zydus Lifesciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,222.9 |
| Previous Close | Rs 1,212 |
| Today's Move | +Rs 10.9 (+0.9%) |
| Open | Rs 1,219.95 |
| High | Rs 1,232 |
| Low | Rs 1,208.3 |
| Turnover | Rs 1.45 crore |
| Market Capitalisation | Rs 1,19,899.96 crore |
Zydus Lifesciences Ltd. (ZYDUSLIFE) traded at Rs 1,222.9 versus the previous close of Rs 1,212, a rise of 0.9%. The stock opened at Rs 1,219.95, reached a high of Rs 1,232 and touched a low of Rs 1,208.3.
Zydus Lifesciences Share Price Today closed the gap between the prior close and the intraday high, with the stock moving from Rs 1,212 to Rs 1,222.9. The day change of Rs 10.9 translates into a 0.90% rise. The session opened at Rs 1,219.95, traded between Rs 1,208.3 and Rs 1,232, and finished close to the day’s top end. Turnover stood at Rs 1.45 crore.
The most important factual point is that the day high of Rs 1,232 equals the supplied 52-week high, so the market witnessed a fresh one-year high in Zydus Lifesciences Share Price today. That makes the stock news relevant for readers scanning stocks in news, market updates and Indian stock market headlines. On Univest, this kind of price action is presented together with the day’s range, the close and the valuation context so the event can be read in one place. The supplied data confirms the price event; it does not establish a company-specific reason for the move.
Zydus Lifesciences Ltd. (ZYDUSLIFE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,19,899.96 crore |
| P/E Ratio | 26.79x |
| P/B Ratio | 4.48x |
| ROE | 19.69% |
| ROCE | 21.39% |
| EPS | Rs 45.24 |
| Book Value Per Share | Rs 270.31 |
| Dividend Yield | 0.08% |
Zydus Lifesciences Ltd. (ZYDUSLIFE) fundamental metrics show P/E 26.79x, P/B 4.48x, ROE 19.69%, ROCE 21.39%. These figures provide context only and are not a buy or sell signal.
Zydus Lifesciences Ltd. has a market capitalisation of Rs 119899.96 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 26.79x, P/B at 4.48x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.69% and ROCE of 21.39%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 45.24, book value per share of Rs 270.31, dividend yield of 0.08%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.86x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 26.79x |
| Benchmark Median P/E | 32.86x |
| Benchmark Average P/E | 49.14x |
| Benchmark P/E Range | 3.46x to 707.31x |
| Company P/B Ratio | 4.48x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 19.69% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 21.39% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 1,19,899.96 crore |
| Benchmark Median Market Cap | Rs 782.41 crore |
Zydus Lifesciences Ltd. (ZYDUSLIFE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 26.79x, which is below the benchmark median of 32.86x, a difference of -18.47%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROE of 19.69%, which is above the benchmark median of 11.7%, a difference of +68.29%. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROCE of 21.39%, which is above the benchmark median of 13.46%, a difference of +58.92%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Cipla Ltd. | CIPLA | 1,12,875.68 | 33.29 | 3.19 | 11.83 | 16 |
| Laurus Labs Ltd. | LAURUSLABS | 1,08,116.47 | 99.43 | 19.28 | 18.31 | 18.2 |
| Mankind Pharma Ltd. | MANKIND | 1,02,247.25 | 49.33 | 5.99 | 12.69 | 13.24 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 1,00,395.34 | 31.67 | 2.67 | 11.69 | 13.75 |
| Aurobindo Pharma Ltd. | AUROPHARMA | 98,464.42 | 26.35 | 2.51 | 9.93 | 12.76 |
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 26.79x compared with the displayed peer median of 33.29x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.69% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 21.39% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a market capitalisation of Rs 1,19,899.96 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Zydus Lifesciences
- Zydus Lifesciences Share Price hit a fresh 52-week high of Rs 1,232 in today’s session.
- The stock last traded at Rs 1,222.9, which was Rs 10.9 above the previous close of Rs 1,212.
- Market capitalisation stood at Rs 1,19,899.96 crore.
- P/E was 26.79, below the industry median of 32.86 and the industry average of 49.14.
- ROE at 19.69% and ROCE at 21.39% were both above the same-industry median and average benchmarks.
About Zydus Lifesciences
Zydus Lifesciences Ltd. is classified in Healthcare and the Pharmaceuticals & Drugs industry. Those sector and industry labels are the verified business identifiers available in the data used for this Zydus Lifesciences Share Price article. For readers following Zydus Lifesciences Company News or Zydus Lifesciences Latest News, the most relevant verified company context here is the market classification and the financial profile attached to the listed entity.
On Univest, this company overview sits alongside Zydus Lifesciences Share Price Live data, valuation ratios and share price history so readers can connect the current market event with the broader stock profile. The article remains limited to the verified data supplied for this update.
Track Zydus Lifesciences Share Price on Univest
Use Zydus Lifesciences Ltd. (ZYDUSLIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Zydus Lifesciences Share Price on Univest for live share price updates, shareholding pattern, valuation ratios, 52-week levels, market cap, sector context and company-level market insights. Univest also presents Zydus Lifesciences Stock Analysis in a single place for quick review.
For users searching Zydus Lifesciences Share Price Today, Zydus Lifesciences Stock News or Zydus Lifesciences Latest News, Univest is designed to keep the event-led update and the fundamental backdrop together.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Zydus Lifesciences Share Price hit the news today?
Ans. Zydus Lifesciences Share Price drew attention because the stock touched a fresh 52-week high at Rs 1,232 and last traded at Rs 1,222.9. The data confirms the price event but does not establish a company-specific catalyst.
What is the current Zydus Lifesciences Share Price today?
Ans. The current Zydus Lifesciences Share Price is Rs 1,222.9. It was up 0.90% from the previous close of Rs 1,212, and the session high matched the 52-week high of Rs 1,232.
What is the 52-week high for Zydus Lifesciences Share Price?
Ans. The fresh 52-week high for Zydus Lifesciences Share Price is Rs 1,232. The stock traded close to that level through the session and finished with a gain of Rs 10.9 over the previous close.
What does Zydus Lifesciences market cap indicate?
Ans. Zydus Lifesciences market cap is Rs 1,19,899.96 crore. Market capitalisation indicates company size in the listed market and helps investors compare the stock with peers in the Pharmaceuticals & Drugs industry.
How does Zydus Lifesciences compare on valuation?
Ans. Zydus Lifesciences has a P/E of 26.79 and a P/B of 4.48. Its P/E is below the industry median and average, while its P/B is above the industry median and slightly above the average.
How strong are Zydus Lifesciences profitability ratios?
Ans. Zydus Lifesciences reports ROE of 19.69% and ROCE of 21.39%. Both are above the same-industry median and average figures in the supplied benchmark, which provides useful fundamental context. ROE stands at 19.69%.
What are Zydus Lifesciences EPS and book value?
Ans. Zydus Lifesciences EPS is Rs 45.24 and book value per share is Rs 270.31. EPS shows earnings attributable to each share, while book value reflects accounting net worth per share.
What is the dividend yield for Zydus Lifesciences Share Price?
Ans. The supplied dividend yield for Zydus Lifesciences is 0.08%. Dividend yield is historical data based on the current price, so it should be read alongside the company’s valuation and profitability metrics.
How does Zydus Lifesciences compare with healthcare peers?
Ans. Zydus Lifesciences has a larger market cap than the five supplied peers in this set and a higher ROE and ROCE than each of them. Its P/E is also below several peer names in the list.
Where can I track Zydus Lifesciences Share Price news?
Ans. You can track Zydus Lifesciences Share Price, Zydus Lifesciences Stock News and related market updates on Univest. The platform combines price, valuation, market cap, sector context and share price history in one place.
